Bipolar disorder is one of the most heritable conditions in medicine, with twin studies consistently showing that genetics account for a large share of who develops it.1PubMed Central. The genetics of bipolar disorder But “heritable” does not mean “determined by a single gene.” Instead, the genetic architecture involves hundreds of common variants, each contributing a small nudge in risk, layered on top of environmental triggers, epigenetic changes, and biological pathways that researchers are still mapping. The picture that has emerged over the past decade is far more interesting and complicated than a simple gene-for-a-disease story.
How Heritable Is Bipolar Disorder, Really?
Twin studies have long been the gold standard for estimating heritability. In bipolar disorder, concordance rates between identical twins hover around 40 to 70 percent, depending on the study and how broadly bipolar spectrum conditions are defined. That range is higher than almost any other psychiatric condition and comparable to highly heritable physical traits. But the fact that identical twins, who share essentially all their DNA, do not always both develop the disorder tells you that genes alone are not enough. Something else has to tip the balance.
Family studies reinforce the pattern. First-degree relatives of a person with bipolar disorder face roughly a tenfold increase in risk compared to the general population. The closer the genetic relationship, the higher the risk. Yet plenty of people with a strong family history never develop bipolar episodes, and a meaningful fraction of those diagnosed have no obvious family connection at all. That gap between heritability estimates and individual prediction is one of the central puzzles in psychiatric genetics.
What Genome-Wide Studies Have Found
The search for specific genes linked to bipolar disorder accelerated with the advent of genome-wide association studies, which scan the DNA of thousands of people to find common variants that show up more often in those with a disorder. A landmark study identified 30 spots in the genome that met strict statistical thresholds for association with bipolar disorder, including 20 that were newly discovered at the time.2PubMed Central. Genome-wide association study identifies 30 loci associated with bipolar disorder Earlier work had already pinpointed a handful of genes, including ANK3 on chromosome 10 and ODZ4 on chromosome 11, as well as ADCY2 and a region near POU3F2 on chromosome 6.3Nature Communications. Genome-wide association study reveals two new risk loci for bipolar disorder
Each of these variants individually raises risk by only a small amount. The strongest signals in early studies carried odds ratios in the range of 1.1 to 1.3, meaning they increased the likelihood of bipolar disorder by roughly 10 to 30 percent over baseline. That is modest by medical standards. The reason the disorder is still so heritable despite each variant being weak is that hundreds, possibly thousands, of these small-effect variants combine. This is what geneticists call a polygenic architecture: many genes, each doing a little, adding up to a lot.
Polygenic Risk Scores and Their Limits
Researchers have tried to bundle all these small genetic effects into a single number called a polygenic risk score, which sums up how many risk variants a person carries. In principle, a high score would flag someone as genetically vulnerable. In practice, the predictive accuracy for bipolar disorder remains too low for clinical use.4PubMed Central. Polygenic Risk Scores for Bipolar Disorder: Progress and Perspectives Scores can show statistical associations across large groups, but they cannot reliably tell an individual whether they will develop the condition. This is a crucial distinction: useful for research, not yet useful in a doctor’s office.
A further wrinkle is that most polygenic risk scores have been developed from samples of predominantly European ancestry, and they perform poorly when applied to other populations.5European Neuropsychopharmacology. Genetic Architecture of Bipolar Spectrum Disorders in Nearly 102,000 Latino Ancestry Individuals Until research catches up with the full diversity of human populations, these scores are limited tools even in principle.
Rare Variants Tell a Different Story
Not all genetic variation is common. Some researchers have looked for rare structural changes in DNA, such as deletions or duplications of large chunks of chromosomes, known as copy number variants. Interestingly, when bipolar disorder is treated as a single diagnostic category, these rare variants do not appear to play a major role. A well-powered study found no difference in the overall burden of rare copy number variants between bipolar cases and healthy controls.6PubMed Central. Contribution of rare copy number variants to bipolar disorder risk is limited to schizoaffective cases
The exception was schizoaffective bipolar disorder, a subtype that shares features with both bipolar disorder and schizophrenia. In those patients, the burden of large, rare structural variants was significantly higher than in controls or in other bipolar subtypes. This finding hints that schizoaffective bipolar disorder may have a partly distinct genetic basis, one that overlaps more with the rare-variant architecture seen in schizophrenia.
Genetic Overlap with Schizophrenia and Depression
One of the more striking findings in psychiatric genetics is just how much genetic overlap exists between bipolar disorder and other conditions. Schizophrenia-associated gene variants show up far more often than expected in people with bipolar disorder.7PLOS ONE. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia Detailed modeling has estimated that bipolar I disorder and schizophrenia share the vast majority of their risk-influencing genetic variants, with one analysis putting the overlap at a Dice coefficient of 0.83, where 1.0 would mean perfect overlap.8PubMed. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder Bipolar I also shares substantial genetic ground with major depressive disorder, though to a lesser degree.
This blurring of genetic boundaries challenges the idea that psychiatric diagnoses carve nature at clean joints. Bipolar disorder, schizophrenia, and major depression are diagnosed based on symptoms, but at the DNA level, they look more like overlapping circles than separate boxes. This has practical implications: it may explain why some people shift between diagnoses over their lifetime, and why some treatments work across diagnostic categories.
Bipolar Type I Versus Type II
Bipolar disorder is commonly divided into type I, characterized by full manic episodes, and type II, which features hypomanic episodes alongside more prominent depressive periods. The genetic underpinnings of these subtypes are not identical. A systematic review found that certain chromosomal regions, including areas on chromosomes 2, 3, and 10, are more specifically tied to type II, with a stronger contribution from combinations of low-effect variants acting on neuroplasticity and signaling pathways.9PubMed. Genetic differences between bipolar disorder subtypes: A systematic review focused in bipolar disorder type II
Additionally, people with bipolar II carry a higher genetic burden for major depression compared to those with bipolar I.10Translational Psychiatry. Clinical and genetic differences between bipolar disorder type 1 and 2 in multiplex families This makes intuitive sense given the clinical picture: bipolar II is dominated by depressive episodes, while bipolar I is defined by the severity of mania. The genetic data suggests these subtypes sit at different positions along a spectrum rather than representing the same condition at different intensities.
Calcium Channels and Circadian Clocks
Identifying risk genes is only the first step. The harder question is what those genes actually do in the brain. Two biological themes have emerged with the most evidence behind them: calcium signaling and circadian rhythm regulation.
Several of the top-ranked bipolar risk genes encode parts of voltage-gated calcium channels, which control the flow of calcium ions into neurons. CACNA1C is probably the best-studied example. Animal research has shown that disrupting this gene in developing brain cells disturbs spontaneous calcium activity, leads to abnormal brain development, and produces anxiety-like behavior.11PubMed Central. Disrupted Cacna1c gene expression perturbs spontaneous Ca(2+) activity causing abnormal brain development and increased anxiety Separate work in patient-derived cells has found that the interaction between calcium channels and potassium channels is weakened in bipolar disorder, and that targeting this interaction can rescue the associated calcium deficit.12bioRxiv. Attenuated CaV1.2-BK channel protein interaction in bipolar disorder Calcium signaling is fundamental to how neurons fire and communicate, so disruptions in this system could plausibly contribute to the mood instability that defines the disorder.
The circadian rhythm connection runs parallel. People with bipolar disorder commonly experience disrupted sleep-wake cycles, altered melatonin and cortisol rhythms, and sensitivity to changes in light exposure.13PubMed Central. Bipolar Disorder, Circadian Rhythm and Clock Genes At the genetic level, variants in clock genes including CLOCK, ARNTL, and TIMELESS have shown suggestive links to bipolar disorder. Individually, many of these associations are modest, but an interaction among variants in three circadian genes (BHLHB2, CSNK1E, and CLOCK) reached statistical significance even after correction for multiple testing.14PubMed Central. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm The idea that a faulty internal clock contributes to mood cycling is appealing because it maps neatly onto what patients actually experience: mania often arrives with dramatically reduced sleep, while depression brings oversleeping and lethargy.
When Environment Meets Genetics
Genes do not operate in a vacuum. Childhood trauma, in particular, appears to interact with genetic vulnerability in meaningful ways. Research has found that childhood adversity can interact with genes in several biological pathways, including the stress hormone axis, serotonin signaling, neuroplasticity, and calcium signaling, to lower the age at which bipolar disorder first appears or to increase the risk of suicide.15PubMed Central. The role of childhood trauma in bipolar disorders One study specifically found that people carrying a higher genetic risk score who also reported more adverse childhood experiences developed the disorder earlier than those with either factor alone.16Translational Psychiatry. Interaction between adverse childhood experiences and polygenic risk in patients with bipolar disorder
An exploratory analysis looking for specific gene-environment interactions found that while no single variant reached significance on its own, variants in genes related to calcium channel activity were collectively more likely to interact with trauma to influence the age of onset.17PubMed Central. Genetic and childhood trauma interaction effect on age of onset in bipolar disorder: An exploratory analysis The calcium channel theme keeps showing up across different levels of analysis, from GWAS hits to animal models to gene-environment studies, which strengthens the case that this pathway is genuinely important.
Epigenetics and How Gene Expression Changes
Beyond the DNA sequence itself, the way genes are switched on and off matters. Epigenetic modifications, including chemical tags on DNA and changes to the proteins that package it, have been found in bipolar disorder. A critical review of the literature identified DNA methylation, histone modifications, and non-coding RNAs as the major reported mechanisms, with some of these changes also associated with mood-stabilizing medications like lithium and valproate.18PubMed. Epigenetics in bipolar disorder: a critical review of the literature This raises an intriguing chicken-and-egg problem: are the epigenetic changes a cause of the disorder, a consequence of it, or a result of treatment? The honest answer is that we do not know yet, but the field is actively investigating.
Genetics and Lithium Response
One of the more directly useful applications of genetic research is understanding why some people respond well to lithium and others do not. Lithium remains one of the most effective mood stabilizers, but it works dramatically better for some patients than others. A large genome-wide study identified a cluster of linked variants on chromosome 21 that were associated with lithium response. In a follow-up sample, carriers of the response-associated variants had a nearly fourfold lower rate of relapse compared to those without them.19PubMed Central. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study Separately, a variant in the ACCN1 gene, which encodes an ion channel that is actually permeable to lithium, has also been linked to treatment response.20PubMed. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder
Neither finding is ready for routine clinical testing yet, but they point toward a future where a genetic profile could help match a patient to the medication most likely to work for them, potentially sparing months or years of trial and error.
Shared Genes with Heart and Metabolic Disease
People with bipolar disorder have higher rates of cardiovascular disease, obesity, and diabetes than the general population. This has traditionally been attributed to medication side effects and lifestyle factors, and those clearly play a role. But genetic analysis has revealed that the overlap may also be baked into the DNA. A systematic review identified two dozen genes that appear to be shared between mood disorders and cardiometabolic conditions, with pathway analysis pointing to shared biological processes including stress hormone signaling, circadian rhythm pathways, and dopamine feedback loops.21PubMed Central. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies This genetic pleiotropy, where the same genes influence multiple seemingly unrelated conditions, suggests that the physical health problems associated with bipolar disorder are not purely side effects of treatment. Some of the shared risk may be biological from the start.
Cognitive Traits in Unaffected Relatives
Genetics can also leave subtler traces that fall short of a diagnosis. Research into cognitive endophenotypes, measurable cognitive traits that track with genetic risk, has found that problems with verbal learning and certain types of verbal fluency appear not just in people with bipolar disorder but also in their high-risk relatives who have never developed any mood symptoms.22PubMed. Cognitive endophenotypes in a family with bipolar disorder with a risk locus on chromosome 4 These subtle cognitive patterns may reflect the underlying genetic risk more directly than mood episodes do, which are influenced by environment, stress, and dozens of non-genetic factors. Studying these intermediate traits could eventually help identify who is genetically vulnerable before any symptoms appear.
Why Bipolar Genes Persist in the Population
If bipolar disorder carries serious fitness costs, including higher mortality and significant impairment, why haven’t evolution and natural selection weeded out the responsible genes? One leading hypothesis is that the same genetic variants that cause illness in large doses confer advantages in smaller doses. A review of bipolar disorder and creativity found evidence for shared genetic vulnerability: moderate genetic loading for bipolar risk may be associated with creative traits, which could offer social and reproductive advantages that keep the genes circulating in the population.23PubMed. Creativity and Bipolar Disorder: A Shared Genetic Vulnerability
Consistent with this idea, bipolar risk genes turn out to be highly conserved across species and enriched for genes considered essential to survival.24PubMed. Candidate risk genes for bipolar disorder are highly conserved during evolution and highly interconnected They are not junk DNA that evolution has not yet cleared out. They are deeply embedded in fundamental biological processes, which is precisely why they are hard to eliminate: removing them entirely would likely cause other problems. The genes that raise bipolar risk may be the same ones doing important work in brain development, energy regulation, and neural connectivity.
Ethical Questions Around Genetic Testing
As the science advances, genetic testing for mental illness is likely to become more common. This raises questions that the research community is only beginning to grapple with. One concern is comprehension: studies have found gaps in what both psychiatrists and genetic counselors understand about the nature of polygenic risk, which limits their ability to communicate results accurately to patients.25PubMed Central. Anticipating the Ethical Challenges of Psychiatric Genetic Testing A polygenic risk score is not a diagnosis and not a destiny, but the nuance of “you have a statistically elevated probability based on common variants, most of which we do not fully understand” is easy to lose in a clinical conversation.
There are also questions about discrimination. Could a high polygenic risk score affect insurance coverage, employment, or custody decisions? Existing genetic non-discrimination laws were written with single-gene conditions in mind and may not adequately cover polygenic psychiatric risk. For now, the technology is not clinically actionable enough for these concerns to be urgent, but the ethical infrastructure needs to be built before the science arrives at the clinic door, not after.